ANAPTYSBIO INC (ANAB) Stock Cash Flow
NASDAQ:ANAB - Nasdaq - US0327241065 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -140.62M | -145.23M | -163.62M | -128.72M | -57.80M | |||
| Depreciation Amortization | 589.00K | 606.00K | 652.00K | 680.00K | 620.00K | |||
| Change In Working Capital | -56.46M | -66.33M | -324.00K | 6.84M | -7.49M | |||
| Interest Paid | N/A | 42.13M | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 87.72M | 75.61M | 42.49M | 47.62M | 18.75M | |||
| OPERATING CASH FLOW | -108.78M | -135.34M | -120.80M | -73.59M | -45.92M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -366.00K | -358.00K | -807.00K | -360.00K | -1.37M | |||
| Other Investing Activity | 41.99M | 95.76M | 145.56M | -394.49M | 40.20M | |||
| INVESTING CASH FLOW | 41.63M | 95.40M | 144.75M | -394.85M | 38.84M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Stock Issued/Repurchased | 95.44M | 100.39M | -47.53M | 11.83M | 2.55M | |||
| Other Financing Activity | 16.66M | 26.67M | -11.77M | 32.19M | 249.75M | |||
| FINANCING CASH FLOW | 112.10M | 127.05M | -59.30M | 44.02M | 252.30M | |||
| CHANGE IN CASH | 44.94M | 87.11M | -35.34M | -424.42M | 245.22M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -108.78M | -135.34M | -120.80M | -73.59M | -45.92M | |||
| Capital Expenditure | -366.00K | -358.00K | -807.00K | -360.00K | -1.37M | |||
| FREE CASH FLOW | -109.15M | -135.69M | -121.61M | -73.95M | -47.29M | |||
All data in USD